| 2021-08-27 | Sale | Prelude Therapeutics Incorporated PRLD | Chief Scientific Officer | 6,014 0.0124% | $35.91 | $215,967 | -76.42% | |
| 2021-08-26 | Sale | Prelude Therapeutics Incorporated PRLD | Chief Scientific Officer | 1,700 0.0038% | $35.19 | $59,819 | -74.05% | |
| 2021-08-13 | Sale | Prelude Therapeutics Incorporated PRLD | Chief Scientific Officer | 2,286 0.0054% | $35.07 | $80,161 | -70.5% | |
| 2021-07-27 | Sale | Prelude Therapeutics Incorporated PRLD | Chief Scientific Officer | 20,000 0.0442% | $35.47 | $709,380 | -71.1% | |
| 2021-05-07 | Sale | Prelude Therapeutics Incorporated PRLD | Chief Scientific Officer | 10,000 0.0213% | $40.82 | $408,192 | -61.04% | |
| 2021-04-08 | Sale | Prelude Therapeutics Incorporated PRLD | Chief Scientific Officer | 4,630 0.0103% | $38.34 | $177,504 | -49.95% | |
| 2021-04-07 | Sale | Prelude Therapeutics Incorporated PRLD | Chief Scientific Officer | 15,370 0.0334% | $39.31 | $604,144 | -43.04% |